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Abstract
Rationale: Researchers tend to study Latinos as a single group but recent asthma research
confirmed differences among Latino subgroups. Variations in controller medication adherence
may be a factor in the observed health disparities between Mexican and Puerto Rican children.
Adherence is not a stable phenomenon, however, there is a paucity of data on patterns of
adherence, sociodemographic predictors of patterns, and variations in asthma-related acute
healthcare utilization by adherence pattern among Latino sub-groups.
Objectives: Identify patterns of inhaled corticosteroid medication adherence over twelve
months among Mexican and Puerto Rican children with persistent asthma; examine sociodemographic predictors of adherence patterns by ethnicity; and investigate asthma-related
acute healthcare utilization based on these patterns.
Methods: We analyzed controller medication Doser data from Mexican and Puerto Rican
children (n=123; ages 5-12 years) with persistent asthma who participated with their caregivers
in a longitudinal, non-intervention study (Phoenix, AZ and Bronx, NY). Interview and medical
record data were collected at enrollment, 3, 6, 9, and 12 months post-enrollment.
Results: 47%-53% of children had poor adherence (<50%) over each of the follow-up periods
(cross-sectional). Children with lowest adherence were Puerto Rican, from non-poor families, or
female. Longitudinal latent class analysis yielded 4 adherence classes: poor; moderate;
declining adherence; and increasing adherence. Puerto Rican children had significantly higher
odds of “Decreasing” (OR=2.86; 95% CI, 0.40 to 20.50) and “Poor” (OR=5.62; 95% CI, 1.44 to
21.90) adherence compared to Mexican children. Females had significantly greater odds of
“Decreasing” (OR=4.80; 95% CI, 0.73 to 31.74) and “Poor” (OR=5.20; 95% CI, 1.77 to 15.30)
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adherence group membership compared to Males. The “Decreasing” adherence group was
comprised of only poor children. Children in the “Poor” adherence class had the highest mean
number of acute visits and ED visits/hospitalizations across all assessment periods.
Conclusions: This study demonstrated that unique ethnicity within Latino populations may be
associated with different risk levels for suboptimal controller medication adherence which may
be a factor in the observed asthma health disparities between Mexican and Puerto Rican
children. Increased understanding of and attention to children’s controller medication
adherence patterns will provide evidence needed to identify children at highest risk for acute
healthcare utilization and offer more intensive intervention using less-intensive approaches for
those at low risk.

Abstract Word Count: 350
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Despite evidence-based guidelines for asthma management and control (1), low asthma
controller medication adherence in children persists, with minority children at greater risk of
non-adherence and poor outcomes than non-minority children (2-6). Adherence to controller
medications is critical and can significantly reduce exacerbations and improve asthma control
(2, 7, 8). Researchers have tended to study Latinos as a single group but recent descriptive
asthma research has confirmed significant heterogeneity among Latino subgroups (particularly
between Mexicans and Puerto Ricans) regarding prevalence, mortality and morbidity, illness
beliefs, and asthma healthcare practices (9-13). Puerto Rican children exhibit the highest rates
of asthma prevalence and mortality among all ethnic groups while Mexican children have the
lowest rates (9, 12). Genetic, environmental, healthcare system, and provider factors (13-15)
cannot totally explain the differences between these two groups.
There is growing evidence about factors leading to non-adherence and interventions
focused on improving adherence. Although an evidence-based cut-off value for good adherence
(16) has not been established, rates >80% are traditionally considered acceptable (16, 17). The
majority of adherence interventions primarily target children with controller medication
adherence <80% assuming that children >80% at initial assessment will remain adherent. There
is evidence that adherence is not a stable phenomenon (17-20), although there is a paucity of
data on patterns of adherence among individuals with asthma and none within sub-groups of
Latino children (21). Souverein et al. (17) examined longitudinal patterns of inhaled
corticosteroid (ICS) medication initiation (21) among a sample of long term care patients
(n=13,922). The results identified periods of non-adherence alternating with periods of regular
ICS use. LaForest et al. (20) examined ICS adherence over 12 months among children and adults
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selectively recruited for high initial adherence. The investigators noted fragmented episodes of
ICS use which typically lasted several months even though all individuals were adherent at
baseline (20). A better understanding of controller medication adherence patterns in children
will provide evidence needed to identify individuals at highest risk for non-adherence and acute
healthcare utilization and offer a more intensive intervention while using less-intensive
approaches for those at low risk preventing waste of precious healthcare resources.
A literature review revealed no studies directly examining controller medication
adherence between Mexican and Puerto Rican children; thus these analyses fill a critical gap in
our knowledge and offer insights to factors leading to asthma health disparities between these
Latino sub-groups. The objectives of these secondary analyses were to: 1) identify patterns of
children’s ICS medication adherence over a 12 month assessment period in a sample of
Mexican and Puerto Rican children with persistent asthma; 2) examine sociodemographic and
seasonal predictors of adherence patterns and; 3) investigate asthma-related acute healthcare
utilization based on these patterns. To the best of our knowledge, this was the first study to
examine objectively measured longitudinal patterns of ICS medication adherence in children,
explore heterogeneity in adherence patterns within a sample of Latino children, and link those
patterns to clinical outcomes.

Methods

We analyzed ICS medication data from a sample of Mexican and Puerto Rican children with
persistent asthma requiring daily controller medications (ages 5-12 years) who participated
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with their caregivers in a longitudinal, non-intervention study (Phoenix, AZ and Bronx, NY). The
main study tested an explanatory, integrated multi-factorial model investigating the interaction
of individual characteristics, cultural and experiential and healthcare system factors, and socialenvironmental context that lead to disparities between these two Latino sub-groups. Children
and caregivers were recruited from two school-based health clinics and the Breathmobile in
Phoenix, Arizona and two inner-city hospital asthma clinics in Bronx, New York. A total of 267
child/caregiver dyads were enrolled in the main study. Structured interviews were administered
to caregivers and shorter interviews and spirometry assessments conducted with children at
enrollment and 3, 6, 9, and 12 months post-enrollment. A retrospective review of children’s
medical records was completed. Objective measures of children’s ICS medication adherence
were assessed by Doser devices (MediTrack Products, Hudson, MA) attached to the top of the
ICS canister at baseline. Data were downloaded at each follow-up visit yielding 12 months of
adherence measures. Due to differences in treatment regimen adherence between inhaled and
oral and combination ICS/LABA controller medications, all children with use of oral and/or
combination ICS/LABA medications were excluded (n=73) from these analyses. Two children
had no record of controller or quick relief medication prescriptions. We had Doser data on a
subsample of 123 of 192 children (64.1%) prescribed inhaled corticosteroids. The study was
approved by the Institutional Review Boards of the Arizona State University, Phoenix Children’s
Hospital, Scottsdale Healthcare and Albert Einstein College of Medicine.
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Sociodemographic Characteristics
All enrolled participants self-identified as Mexican or Puerto Rican. We obtained child’s sex,
age, and asthma duration (number of months since diagnosis); family perception of poverty;
caregiver’s marital status and education; and season of interview. Due to the socio-legal climate
in Phoenix, we did not ask for annual income demonstrating sensitivity to the challenges these
families were facing. To assess caregivers’ perception of poverty, a measure adapted by Gore et
al. (22) asked “What best describes your family’s standard of living?” Response choices ranged
from 1=Very well off to 6=Poor and was dichotomized as Poor=Nearly Poor or Poor. All enrolled
children/caregiver dyads were Medicaid/Medicaid-eligible and received their asthma
medications free from the participating clinics.

Seasonality
Using each interview date, we created the season that baseline and follow-up interviews were
conducted, adherence data captured, and acute asthma-related healthcare utilization occurred.
Seasons were defined as: Spring=March-May; Summer=June-August; Fall=SeptemberNovember; Winter=December-February.

Clinician-rated Asthma Severity
Clinician ratings of children’s asthma severity were conducted per clinical guidelines (1). The
ratings were based on clinicians’ assessment of impairment given the caregivers’ and children’s
responses to structured questions regarding daytime and nocturnal symptoms, activity
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limitations, short-acting β2 agonist use for the 2-4 week period prior to the interview,
spirometry, and risk of adverse events. All ratings were completed by pediatric pulmonologists.

Adherence
Doser devices were attached to the child’s ICS canister at the baseline visit. Doser data were
downloaded at each assessment period (M3=baseline-month 3; M6=month 3-month 6;
M9=month 6-month 9, and M12=month 9-month 12) yielding 12 months of adherence data.
The Doser devices recorded the number of actuations each day for the prior 30 days. For
medications where we could not attach the Doser due to built-in counters, we captured the
counter data at each visit. Adherence data were cleaned per procedures outlined by McQuaid,
Kopel, Klein & Fritz (23). Adherence was calculated as the # doses taken per day/# prescribed
doses per day x 100. Daily adherence was truncated to 100% to account for accidental
actuations (e.g., bumping in a backpack) or intentional actuations due to trying to make up for
missed doses the previous day. Average adherence and adherence categories were created
(<50%=Poor, 50-80%=Moderate, >80%=Good) at each time period (24).

Acute Healthcare Utilization
Children’s medical records from the recruitment site were reviewed for 12 months prior to
enrollment and the 12 month study period to obtain counts of acute and ED asthma visits and
hospitalizations. Asthma-related ED visits and hospitalizations were combined due to the low
frequency. Because asthma-related healthcare visits may have occurred outside the child’s
medical home, caregiver reports were checked against the medical record based on visit date
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(+/- one month to account for recall errors). In cases where the medical record and caregiver
dates were congruent, medical record data were used. Where there was a caregiver report but
no medical record visit for that date, caregiver report was used. If a visit was recorded in the
medical record but not reported by the caregiver, medical record data were used.

Statistical Analyses
Only data for children prescribed an ICS medication and who had at least 2 adherence data
points were analyzed. Cross-sectional descriptive chi-square analyses examined adherence by
ethnicity, child sex and age, poverty, and season. Structural equation modeling and longitudinal
latent class analysis (LLCA) explored patterns of adherence over time and acute healthcare
utilization by adherence class. The LLCA also examined sociodemographic characteristics
(ethnicity, marital status, poverty, caregiver education, child’s age, sex, and asthma duration,
and number of family members with asthma) to identify predictors of class membership.
Interaction effects for ethnicity with caregiver marital status, education, poverty, and child sex
were examined. Reference groups were Puerto Rican, female, non-poor, summer, and
“Moderate” adherence group. Model selection was based on the log likelihood, Bayesian
Information Criteria (BIC), and entropy. Models specifying 2, 3, and 4 classes were run and fit
statistics compared to determine the best fitting model (25, 26). Statistical significance was set
at p<.10, the convention for structural equation modeling and LLCA.
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Results

A total of 267 child/caregiver dyads enrolled and completed baseline measures and
assessments. We had adherence data for 123/192 children prescribed non-combination ICS
medications (64.1%). Analyses were conducted (data not shown) to examine whether children
who were missing adherence data were different from those who had adherence data based on
ethnicity; recruitment site; number of family members with asthma; caregivers’ marital status,
education, perception of poverty, reported use of controller medication in the past month, age
and sex; and child’s sex, age, asthma duration and severity. Children who were missing
adherence data were more likely to not have used controller medications in the past month,
had mild or severe persistent asthma, and had caregivers who were older and high school
graduates. There were no differences by ethnicity.
Table 1 presents the sample characteristics by ethnic group. Puerto Rican caregivers
were less likely to be married or poor and more likely to have graduated from high school.
Puerto Rican children were younger, had higher clinician ratings of severe persistent asthma,
and lower likelihood of caregiver-reported controller medication use in the past month
compared to Mexican children.

Cross-sectional Analyses
Figure 1 illustrates cross-sectional adherence by time. Good adherence (>80%) at each time
period was low (14%-23%) with the largest proportion of children demonstrating poor
adherence (47%-53%). Puerto Rican children had the highest proportion of poor adherence at
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each time period (63%-80%) compared to Mexican children (40%-49%)(see Figure E1A in the
Online Supplement). Although a higher proportion of Mexican (19%-23%) compared to Puerto
Rican children (0%-21%) had good adherence, overall, these proportions are quite low. Because
all of the Puerto Rican children were enrolled at the Bronx hospital clinics, we conducted
additional analyses to investigate whether adherence differences were due to ethnicity or clinic
setting. A sub-group analysis was conducted comparing adherence for Mexican and Puerto
Rican children enrolled at the Bronx hospital clinic sites. More Puerto Rican children in the
hospital clinics had poor adherence at every time period (71%-80%) compared to Mexican
children from the same clinic (33%-63%). Additionally, we examined adherence by site to
determine whether adherence was lowest at the hospital-based clinics in the Bronx compared
to the other sites. The school-based health centers in Phoenix actually had the lowest
adherence across all assessment periods (range 10%-31%) followed by the hospital-based
clinics (range 34%-38%) with the Breathmobile consistently having the highest adherence
(range 50%-56%). These findings support our conclusion of ethnic differences unrelated to clinic
site. Good adherence was low for both sexes ranging from 5% to 23% (see Figure E1B in the
Online Supplement). Across all time periods, females demonstrated the highest proportions of
poor adherence (55%-77%). At M3 and M6, more non-poor children demonstrated poor
adherence compared to poor children. These differences dissipated over time (see Figure E2A
in the Online Supplement). There were no seasonal differences in adherence at any time period
(see Figure E2B in the Online Supplement). Similar adherence proportions were observed for
younger and older children with the majority having poor adherence across all time periods
(data not shown).
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Longitudinal Latent Class Analysis
We tested 2, 3 and 4 class models examining adherence patterns from baseline through 12
months. Multiple imputation was used to impute missing data for the 123 children that had
adherence data for at least 2 time periods. The LLCA revealed that the four class solution was
the best of the three models tested. These classes of adherence are: poor (47%); moderate
(31%); declining adherence (good or moderate adherence transitioning to poor adherence)
(7%); and increasing adherence (poor adherence shifting to moderate or good adherence)
(15%) (Figure 2). Table 2 presents the results for significant predictors of adherence class
membership; ethnicity, child sex, and poverty. No differences were observed for marital status,
caregiver’s education, child’s age, asthma duration, or number of family members with asthma.
Puerto Rican children had significantly higher odds of being in the “Decreasing” and “Poor”
adherence groups compared to Mexican children. Females had significantly greater odds of
being in the “Decreasing” and “Poor” adherence groups compared to Males; no females were
in the “Improving” adherence class. The “Decreasing” adherence class was comprised of only
poor children and these children also had lower odds of being in the “Improving” adherence
class. No interaction effects of ethnicity with caregiver marital status, education, poverty, or
child sex were observed (data not shown).
Differences in asthma-related healthcare utilization (i.e., acute care visits and ED
visits/hospitalizations) were examined by adherence class and modeled by assessment period
across 12 months. These results are presented as forest plots (Figures 3 and 4, respectively)
where the x-axis represents the mean difference and I2 is a measure of heterogeneity between
the groups. For these analyses, I2 >50% is considered statistically significant. Because of small
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class sizes and low frequency of healthcare visits, we examined effect sizes to ascertain
clinically meaningful (effect size >=.20) differences between classes for acute care visits and ED
visits/hospitalizations in addition to statistically significant differences. For acute visits,
statistically significant heterogeneity was observed among the different adherence classes
(excluding Month 9) as evidenced by I2 values ranging from 63%-78%. With the exception of
Month 9, small to moderate clinically meaningful differences were also noted over time (effect
sizes ranging from 0.22 to 0.55) although there was no discernable pattern to these differences.
Figures E3A in the Online Supplement plots the mean number of acute visits at each
assessment period by adherence class. The “Moderate” adherence class had the lowest acute
visits through M9 but demonstrated a large increase from M9 to M12. The “Decreasing”
adherence class initially had the highest acute visits which decreased through M9 and
plateaued at M12. At M3, the “Increasing” adherence class had low acute visits which peaked
at M6 and then declined through M9 and M12. With the exception of M9, the “Poor”
adherence class had the highest acute visits.
A different pattern emerged for ED visits/hospitalizations. Statistically significant
heterogeneity between adherence classes was observed only at Month 6 and Month 9 (I2=80%
and 73%, respectively). However, only the difference between the poor and moderate
adherence classes was clinically meaningful (effect size=.23). At M3, all four classes had
equivalent ED visits/hospitalizations. At M6, the “Poor” adherence class had significantly
greater ED visits/hospitalizations compared to the remaining classes, a finding which held
across M9 and M12 (Figure E3B in the Online Supplement). The “Moderate” adherence class
had the lowest ED visits/hospitalizations at M6 but demonstrated steadily increasing visits
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through M9 and M12. The “Increasing” adherence class exhibited steady declines in ED
visits/hospitalizations from baseline through M9 which then dramatically increased at M12. The
“Decreasing” adherence class had relatively stable ED visits/hospitalizations across the 12
month assessment period. Examination of the between class differences revealed clinically
meaningful differences for almost all contrasts (excluding M6 increasing vs. decreasing
adherence and M12 increasing vs. poor adherence) from M3 through M12 months.

Discussion

These results add to our emerging evidence on patterns of ICS medication adherence in
children. Notably, in our cross-sectional analyses, few children had adherence rates consistently
>80% and less than one third were classified as having moderate adherence (50%-80%). Our
LLCA identified four classes of adherence with the majority (78%) classified as poor or
moderate. This finding supports the tendency to focus interventions on individuals with
adherence <80% using a risk/benefit approach. These results revealed that acute healthcare
utilization differed by adherence class over time. Children in the “Poor” adherence class had the
highest utilization across the entire 12 month period but there was an unexplained drop in
acute visits between M6 and M9 which was not explained by season. The “Decreasing”
adherence group had steadily declining acute visits and relatively stable ED
visits/hospitalizations over the 12 month assessment period which may be due to caregivers
stepping down therapy or stopping therapy when the child has been asymptomatic for a period
of time. Several studies have reported that caregivers have a strong desire for their children to
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be medication-free and thus, discontinue using controller medications when the child no longer
“has asthma” (27, 28). As we anticipated, children in the “Moderate” adherence group also had
the lowest number of acute visits through M9. An unexpected finding was a dramatic increase
in acute visits between M9 and M12, similar to what we observed for the poor adherence class.
Again, this was not due to seasonal effects. When the “Improving” adherence class emerged,
given that this was not an intervention study, we hypothesized that possibly an ED visit or
hospitalization was the “trigger” for getting back on track with the prescribed regimen and this
group of caregivers intervened early enough to prevent ED visits and hospitalizations. There is
some support for this as evidenced by declining acute visits from M3 through M12 and slightly
declining ED visits/hospitalizations through M9. However, this group had a substantial increase
in ED visits/hospitalizations from M9 to M12 months almost equaling the poor adherence class.
Once more, this increase was not associated with season.
It is worth noting that evidence from prior research suggests that adherence in Latino
children is strongly affected by children’s and caregiver’s symptom perception which is not
highly accurate (29-31) and differs between Puerto Rican and other Latino sub-groups (32, 33);
cultural beliefs about asthma and medication use (27, 28); and other socio-economic factors.
This suggests close clinical monitoring of ICS medication use and development of targeted
interventions to address inaccurate symptom perception and sub-optimal treatment patterns in
this at-risk population. Given that pediatric adherence is heavily influenced by parental
involvement, effective intervention may require tailoring to specific cultural needs at both adult
(parent, grandparent) and child level.
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Our study also is the first study showing that unique ethnic identity within Latino
populations may be associated with different risk levels and highlights the role of
socioeconomic factors. We demonstrated that Puerto Rican children were at substantially
greater risk of poor adherence compared to Mexican children and that poor adherence led to
the highest acute healthcare utilization across time. This supports our notion that adherence
patterns may be a factor in Latino children’s asthma health disparities. Our findings are
pertinent in addressing the differences in asthma burden between Mexican and Puerto Rican
children. Puerto Rican children, on average, were half as adherent as Mexican children. Lack of
adherence to ICS medications in our study highlights the role of these medications in the lack of
bronchodilator responsiveness observed to a higher extent among Puerto Rican compared to
Mexican children (36). It is unsurprising that poverty adversely affects adherence. Lack of
adherence to medications in poor families is likely multifactorial. For many of these families
lacking sufficient resources, purchasing controller medications may be a lower priority when
there are competing demands for limited resources. Although Puerto Ricans perceived
themselves as less poor than Mexicans and all study children received their ICS medications for
free, they had lower adherence suggesting that factors other than poverty contributed to their
lack of adherence. Higher asthma burden has been reported among female children compared
to male (4, 37) and our findings confirm that with females exhibiting greater odds of decreasing
and poor adherence. One explanation may be that as girls get older there is social pressure to
look and act a certain way and using an inhaler may make them feel “different.”
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Limitations
There are several important limitations. Objective measures of adherence were based on Doser
tracking devices attached to the child’s ICS canister. The devices we used were capable of only
storing the most recent 30 days of usage. Thus, we were unable to examine adherence
continuously across the 12 month assessment period. Only 64% of the children had valid
adherence data, thus, poor medication adherence may actually be under-estimated because
this sub-sample may represent those individuals who were reliable enough to bring the
medications to the visits. Additionally, several of the class sizes were small and thus, we may
not have had adequate statistical power to assess longitudinal between adherence class
differences. Lastly, we did not have pharmacy fill/refill data to compute the medication
possession ratio or controller to total medication ratio as additional measures of adherence.

Implications and Future Research
Our findings suggest medication adherence is a major contributor to disease burden and acute
healthcare utilization among urban Latino children. To the best of our knowledge, this was the
first study which characterized longitudinal patterns of children’s asthma ICS medication
adherence and demonstrated differing risk levels for non-adherence based on ethnicity within
the Latino population. Future research should further explore these patterns and risk factors
among more heterogeneous Latino samples to inform targeted adherence intervention
strategies. Health technology and wearable sensors are transforming our ability to monitor
adherence beyond simply counting device actuations to assessing inhaler technique and
capturing clinically meaningful data such as exhaled nitrous oxide, cough rate, and respiration
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patterns which can seamlessly upload data through wireless connectivity and Smartphone apps
(38). Given that a significant proportion of children did not have adherence data and our Dosers
could not continuously monitor adherence, future studies should incorporate these monitoring
devices to more precisely examine the intra- and inter-person variability longitudinally and
minimize missing adherence data. This technology could support adherence interventions that
can be tailored to different ethnic sub-groups.
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Table 1. Sample Baseline Characteristics (n=123)
Variable

Mexican
(N=89)

Recruitment Site
Hospital Clinic (NY)
Breathmobile (AZ)
School-based Health Center (AZ)
Season of Baseline Interview
Summer
Fall
Winter
Spring
Child:
Child Sex (% Female)
Clinician-rated Asthma Severity
Mild intermittent
Mild persistent
Moderate persistent
Severe persistent
Any Controller Medication Use in the Past Month (% Yes)
Study Child’s Age (Years)
Asthma Duration (# months since diagnosis)
% Adherent: Month 3
% Adherent: Month 6
% Adherent: Month 9
% Adherent: Month 12
Caregiver
Married (% Yes)
Poor (% Yes)
High School Graduate (% Yes)
Caregiver Sex (% Female)
Caregiver’s Age
# Family Members w/Asthma

Copyright © 2019 by the American Thoracic Society

N (%)

Puerto
Rican
(N=34)
N (%)

17 (19.10)
61 (68.54)
11 (12.36)

34 (100)
0
0

25 (28.09)
21 (23.60)
26 (29.21)
17 (19.10)
N (%)
31 (34.8)

8 (23.53)
12 (35.29)
8 (23.53)
6 (17.65)
N (%)
15 (44.1)

9 (10.34)
27 (31.03)
47 (54.02)
4 (4.06)
78 (87.64)
Mean (SD)
9.53 (2.14)
68.28
(36.22)
47.51
(30.05)
53.47
(31.47)
51.27
(28.68)
53.09
(29.39)
N (%)
45 (50.56)
59 (66.29)
34 (38.20)
85 (95.51)
Mean (SD)
34.57
(6.41)
1.17 (0.73)

3 (9.68)
5 (16.13)
18 (58.06)
5 (16.13)
27 (79.41)
Mean (SD)
8.64 (1.97)
82.21
(33.21)
35.65
(28.91)
35.44
(37.86)
29.94
(27.57)
26.41
(29.29)
N (%)
9 (26.47)
10 (29.41)
19 (55.88)
32 (94.12)
Mean (SD)
36.00 (9.39)
0.82 (1.11)
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Table 2. Sociodemographic Predictors of Controller Medication Adherence Class Membership
Variable
Ethnicity
Improving Adherence
Mexican
Puerto Rican
Decreasing Adherence
Mexican
Puerto Rican
Poor Adherence
Mexican
Puerto Rican
Child Sex
Improving Adherence
Male
Female
Decreasing Adherence
Male
Female
Poor Adherence
Male
Female
Poverty
Improving Adherence
Non-Poor
Poor
Decreasing Adherence
Non-Poor
Poor
Poor Adherence
Non-Poor
Poor
*Moderate adherence is the referent group
Definition of abbreviations: CI=confidence interval; OR=odds ratio

Copyright © 2019 by the American Thoracic Society

Model
χ2
9.15

OR (95% CI)

Referent
.73 (.05, 11.86)
Referent
2.86 (.40, 20.50)
Referent
5.62 (1.44, 21.90)
85.07
Referent
0
Referent
4.80 (.73, 31.74)
Referent
5.20 (1.77, 15.30)
99.49
Referent
.41 (.07, 2.34)
Referent
0
Referent
.74 (.25, 2.13)
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Figure Legends:

Figure 1.

Categorical Cross-Sectional Adherence

Figure 2.

Longitudinal Latent Class Analysis: 4 Class Solution

Figure 3.

Forest Plot of Longitudinal Acute Healthcare Visits by Adherence Class

Figure 4.

Forest Plot of Longitudinal ED Visits/Hospitalizations by Adherence Class
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Proportion of Children in Each Adherence Category
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Month 12
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M9

Moderate (n = 38)

M12
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Study
ID

ES (95% CI)

%
Weight
(I-V)

Month 3
Poor vs. Decreasing
Poor vs. Moderate
Poor vs. Increasing
Decreasing vs. Moderate
Decreasing vs. Increasing
Moderate vs. Increasing
I-V Subtotal (I-squared = 77.5%, p = 0.000)

0.07 (-0.12, 0.25)
0.23 (0.14, 0.32)
0.15 (0.02, 0.28)
0.30 (0.22, 0.38)
0.22 (0.12, 0.32)
0.08 (0.02, 0.14)
0.17 (0.13, 0.21)

1.02
4.21
2.05
5.12
3.22
10.02
25.65

Month 6
Poor vs. Decreasing
Poor vs. Moderate
Poor vs. Increasing
Decreasing vs. Moderate
Decreasing vs. Increasing
Moderate vs. Increasing
I-V Subtotal (I-squared = 63.4%, p = 0.018)

0.45 (-0.11, 1.01)
0.55 (0.28, 0.82)
0.36 (-0.03, 0.75)
0.10 (0.02, 0.18)
0.09 (-0.05, 0.23)
0.19 (0.11, 0.27)
0.16 (0.11, 0.21)

0.11
0.48
0.22
5.00
1.86
5.73
13.41

Month 9
Poor vs. Decreasing
Poor vs. Moderate
Poor vs. Increasing
Decreasing vs. Moderate
Decreasing vs. Increasing
Moderate vs. Increasing
I-V Subtotal (I-squared = 45.2%, p = 0.104)

0.01 (0.01, 0.23)
0.09 (0.03, 0.15)
0.02 (-0.06, 0.10)
0.03 (-0.03, 0.09)
0.14 (0.05, 0.23)
0.11 (0.06, 0.16)
0.07 (0.05, 0.10)

2.94
11.12
5.19
10.02
4.31
11.96
45.53

Month 12
Poor vs. Decreasing
Poor vs. Moderate
Poor vs. Increasing
Decreasing vs. Moderate
Decreasing vs. Increasing
Moderate vs. Increasing
I-V Subtotal (I-squared = 74.6%, p = 0.001)

0.27 (0.10, 0.44)
0.01 (-0.09, 0.11)
0.23 (0.11, 0.35)
0.26 (0.11, 0.41)
0.04 (-0.05, 0.13)
0.22 (0.11, 0.33)
0.13 (0.09, 0.18)

1.22
3.56
2.34
1.51
3.95
2.83
15.41

Heterogeneity between groups: p = 0.000
I-V Overall (I-squared = 73.2%, p = 0.000)
D+L Overall

0.12 (0.10, 0.14)
0.14 (0.10, 0.18)

100.00

-1.01

Decreased Acute Care Utilization

0

Mean Difference

I2=heterogeneity between the groups; >=50% indicates statistically significant
Copyright © differences
2019 by the American Thoracic Society

1.01

Increased Acute Care Utilization

ANNALSATS Articles in Press. Published on 12-March-2019 as 10.1513/AnnalsATS.201807-462OC

Page 29 of 34

Study
ID

ES (95% CI)

%
Weight
(I-V)

Month 3
Poor vs. Decreasing
Poor vs. Moderate
Poor vs. Increasing
Decreasing vs. Moderate
Decreasing vs. Increasing
Moderate vs. Increasing
I-V Subtotal (I-squared = 0.0%, p = 0.996)

0.01 (-0.11, 0.13)
0.03 (-0.03, 0.09)
0.01 (-0.08, 0.10)
0.02 (-0.07, 0.11)
0.02 (-0.09, 0.13)
0.04 (-0.03, 0.11)
0.02 (-0.01, 0.06)

1.20
4.14
2.12
2.17
1.41
3.09
14.14

Month 6
Poor vs. Decreasing
Poor vs. Moderate
Poor vs. Increasing
Decreasing vs. Moderate
Decreasing vs. Increasing
Moderate vs. Increasing
I-V Subtotal (I-squared = 79.5%, p = 0.000)

0.12 (-0.00, 0.24)
0.23 (0.17, 0.29)
0.13 (0.04, 0.22)
0.11 (0.08, 0.15)
0.01 (-0.06, 0.08)
0.10 (0.07, 0.13)
0.11 (0.09, 0.13)

1.09
4.72
2.17
13.42
3.36
19.55
44.32

Month 9
Poor vs. Decreasing
Poor vs. Moderate
Poor vs. Increasing
Decreasing vs. Moderate
Decreasing vs. Increasing
Moderate vs. Increasing
I-V Subtotal (I-squared = 72.5%, p = 0.003)

0.06 (-0.05, 0.17)
0.17 (0.12, 0.22)
0.14 (0.06, 0.22)
0.11 (0.06, 0.16)
0.08 (-0.01, 0.17)
0.03 (-0.01, 0.07)
0.09 (0.07, 0.12)

1.33
5.64
2.57
5.85
2.17
8.89
26.46

Month 12
Poor vs. Decreasing
Poor vs. Moderate
Poor vs. Increasing
Decreasing vs. Moderate
Decreasing vs. Increasing
Moderate vs. Increasing
I-V Subtotal (I-squared = 0.0%, p = 0.933)

0.10 (-0.06, 0.26)
0.06 (-0.02, 0.14)
0.02 (-0.09, 0.13)
0.04 (-0.03, 0.11)
0.08 (-0.01, 0.17)
0.04 (-0.02, 0.10)
0.05 (0.02, 0.08)

0.68
2.70
1.29
3.66
1.86
4.89
15.08

Heterogeneity between groups: p = 0.000
I-V Overall (I-squared = 66.5%, p = 0.000)
D+L Overall

0.09 (0.07, 0.10)
0.08 (0.05, 0.10)

100.00

-.291

Decreased ED/Hospitalization

0

Mean Difference

I2=heterogeneity between groups; >=50% indicates statistically significant differences
Copyright © 2019 by the American Thoracic Society
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Increased ED/Hospitalization
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Online Data Supplement

Longitudinal Patterns of Mexican and Puerto Rican Children’s Asthma Controller Medication
Adherence and Acute Healthcare Utilization
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Supplemental Figure Legend
Figure E1A.

Categorical Cross-Sectional Adherence by Ethnicity

Figure E1B.

Categorical Cross-Sectional Adherence by Child Sex

Figure E2A.

Categorical Cross-Sectional Adherence by Poverty Status

Figure E2B.

Categorical Cross-Sectional Adherence by Season

Figure E3A.

Longitudinal Latent Class Analysis for Acute Visits by Adherence Class

Figure E3B.

Longitudinal Latent Class Analysis for ED Visits/Hospitalizations by Adherence
Class
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Figure E3A. Longitudinal Latent Class Analysis for Acute Visits by Adherence Class
338x190mm (96 x 96 DPI)
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Figure E3B. Longitudinal Latent Class Analysis for ED Visits/Hospitalizations by Adherence Class
338x190mm (96 x 96 DPI)
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